Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial

BACKGROUND: Cutaneous leishmaniasis (CL) is a world-wide health problem which currently lacks effective, affordable and easy to use therapy. Recently, the meglumine antimoniate (MA) intralesional infiltration was included among the acceptable therapies for New World leishmaniasis. While this approac...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramalho, Dario Brock, da Silva, Rosiana Estéfane, de Senna, Maria Camilo Ribeiro, Moreira, Hugo Silva Assis, Pedras, Mariana Junqueira, de Avelar, Daniel Moreira, Saraiva, Lara, Rabello, Ana, Cota, Gláucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012678/
https://www.ncbi.nlm.nih.gov/pubmed/29947651
http://dx.doi.org/10.1590/0074-02760180200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012678/
https://www.ncbi.nlm.nih.gov/pubmed/29947651
http://dx.doi.org/10.1590/0074-02760180200

Ejemplares similares